Skip to main content

Tecomet and Orchid Complete Transaction, Creating a Scaled Global Manufacturing Platform

Written by Customer Service on . Posted in Mergers And Acquisitions.

Global medical manufacturing combination strengthens scale, technical capabilities, global footprint, and supply resilience to support OEM customers

Woburn, MA, and Mason, MI, May 14, 2026 (GLOBE NEWSWIRE) — Tecomet and Orchid Orthopedic Solutions (“Orchid”) today announced the successful closing of their merger, forming a scaled global manufacturing partner serving MedTech and Aerospace & Defense customers. The combined company will operate under the Tecomet name.

Tecomet will offer expanded capabilities across precision machining, additive manufacturing, forging, casting, and advanced finishing, supported by a more integrated and innovation-focused global manufacturing platform. This combination positions Tecomet to support customers across the product lifecycle from product development through full-scale production with greater speed, flexibility, and supply assurance.

Customers will benefit from access to a more comprehensive set of manufacturing capabilities, expanded design and technology services, and a more resilient global supply base through a single partner, supporting both near-term continuity and long-term growth.

Andreas Weller, CEO of Tecomet, has been named CEO of the combined company.

“This combination is about more than scale. It is about building a platform that can meet the increasing complexity and demands of our customers with greater precision, reliability, and speed,” said Mr. Weller. “We are bringing together capabilities that are highly complementary to create a more complete and resilient manufacturing partner.”

As integration begins, the company will maintain a clear focus on operational continuity across all sites. Core priorities including safety, quality, regulatory compliance, and on-time delivery remain unchanged, while dedicated Integration teams coordinate closely to minimize disruption and ensure a seamless transition for customers. Integration will be phased to align capabilities and operations while minimizing disruption.

The combined organization is well-positioned to invest in advanced manufacturing, automation, and operational excellence, further strengthening its ability to support long-term customer growth and innovation.

About Tecomet

Tecomet is a global contract manufacturer serving the Medical Device and Aerospace & Defense markets. Tecomet operates 14 manufacturing locations across five countries, offering capabilities including forging, casting, precision machining, photochemical etching, finishing, additive manufacturing and sterile packaging.

About Orchid

Orchid is a global partner to MedTech OEMs, offering manufacturing services including additive manufacturing, bone in-growth coatings, forging, casting and machining. Orchid specializes in implants, instruments, and innovative technologies within joint reconstruction, hips, knees, spine, trauma, extremities, and dental supported by 10 facilities across the U.S., the U.K., and Switzerland.

CONTACT: Erin House
Tecomet
248-259-5655
erin.house@orchid-ortho.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.